Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A12) inhibits IGF-I action in endometrial cancer cells. (Q53887705)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A12) inhibits IGF-I action in endometrial cancer cells. |
scientific article |
Statements
Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A12) inhibits IGF-I action in endometrial cancer cells. (English)
1 reference
Ilan Bruchim
1 reference
Zohar Attias-Geva
1 reference
Itay Bentov
1 reference
Dale L Ludwig
1 reference
Ami Fishman
1 reference
Haim Werner
1 reference
28 March 2011
1 reference
47
1 reference
11
1 reference
1717-1726
1 reference
1 reference
Identifiers
1 reference